CASTLE BIOSCIENCES, INC. Acquisitions, Net of Cash Acquired
CASTLE BIOSCIENCES, INC. (CSTL) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-02-27
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $0.00.
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2022-12-31 was $0.00.
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2022-09-30 was $305.00K.
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $26.97M.
- CASTLE BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2021 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-02 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $305.00K derived: sum of 2 quarters · filed 2025-02-27 | $26.97M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $305.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $26.97M 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $26.66M 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |